研究者撤销 不同类型的运动对绝经后女性高血压患者认知功能的影响

注册号:

Registration number:

ChiCTR2300073936 

最近更新日期:

Date of Last Refreshed on:

2023-08-23 15:58:09 

注册时间:

Date of Registration:

2023-07-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

研究者撤销 不同类型的运动对绝经后女性高血压患者认知功能的影响

Public title:

Canceled by the investigator. Effects of different types of exercise on cognitive function in postmenopausal women with hypertension

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同类型的运动对绝经后女性高血压患者认知功能的影响

Scientific title:

Effects of different types of exercise on cognitive function in postmenopausal women with hypertension

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王晨 

研究负责人:

马莹 

Applicant:

Wang Chen 

Study leader:

Ma Ying 

申请注册联系人电话:

Applicant telephone:

+86 180 6268 8438

研究负责人电话:

Study leader's
telephone:

+86 135 4652 5728

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

qingshen126@126.com

研究负责人电子邮件:

Study leader's E-mail:

691674899@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

北京体育大学

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区信息路48号

研究负责人通讯地址:

山西省临汾市解放西路17号

Applicant address:

No.48, Information Road, Haidian District, Beijing

Study leader's address:

No.17 Jiefang West Road, Linfen City, Shanxi Province, China

申请注册联系人邮政编码:

Applicant postcode:

100084

研究负责人邮政编码:

Study leader's postcode:

041000

申请人所在单位:

北京体育大学

Applicant's institution:

Beijing Sport University

研究负责人所在单位:

临汾市中心医院

Affiliation of the Leader:

linfen central hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YP2023-11-02号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

临汾市中心医院伦理委员会

Name of the ethic committee:

Linfen Central Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023-05-23 00:00:00

伦理委员会联系人:

朱瑜

Contact Name of the ethic committee:

zhu yu

伦理委员会联系地址:

山西省临汾市解放西路17号

Contact Address of the ethic committee:

No.17 Jiefang West Road, Linfen City, Shanxi Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 151 3573 0968

伦理委员会联系人邮箱:

Contact email of the ethic committee:

drzhuyu@163.com

研究实施负责(组长)单位:

临汾市中心医院

Primary sponsor:

linfen central hospital

研究实施负责(组长)单位地址:

山西省临汾市解放西路17号

Primary sponsor's address:

No.17 Jiefang West Road, Linfen City, Shanxi Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山西

市(区县):

Country:

China

Province:

Shanxi

City:

单位(医院):

临汾市中心医院

具体地址:

山西省临汾市解放西路17号

Institution
hospital:

linfen central hospital

Address:

No.17 Jiefang West Road, Linfen City, Shanxi Province, China

经费或物资来源:

临汾市科技局课题

Source(s) of funding:

Linfen Science and Technology Bureau Subjects

研究疾病:

高血压  

Target disease:

hypertension

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)通过12周不同类型的运动来观察其对绝经后高血压女性患者认知功能和血管功能的效果及可能的作用机制; (2)采用Logistic回归的方法来探讨绝经后高血压女性患者认知功能减退(如视空间/执行功能、命名、记忆、语言、注意力、抽象能力和定向力)等因素分别与血管功能、生长因子、心肺耐力、自主神经功能、炎症和氧化应激的关联; (3)通过12周不同类型的运动来探讨3种不同的运动方式(有氧、抗阻、抗阻结合有氧)对绝经后高血压女性患者的认知功能的影响,并比较何种运动方式是改善绝经后高血压女性患者认知功能减退的最优运动方式。  

Objectives of Study:

(1) Different types of exercise for 12 weeks were used to observe their effects and possible mechanisms of action on cognitive and vascular functions in postmenopausal hypertensive female patients; (2) Logistic regression was used to explore the associations of factors such as cognitive impairment (e.g., visuospatial/executive function, naming, memory, language, attention, abstraction, and orientation) with vascular function, growth factors, cardiorespiratory endurance, autonomic function, inflammation, and oxidative stress, respectively, in postmenopausal hypertensive female patients; (3) To explore the effects of 3 different exercise modalities (aerobic, resistance, and resistance combined with aerobic) on cognitive function in postmenopausal hypertensive female patients through 12 weeks of different types of exercise, and to compare which exercise modality is the optimal exercise modality to ameliorate cognitive decompensation in postmenopausal hypertensive female patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

a.排除标准:(1)绝经期之前,不属于以上条件;(2)血压未超出上述范围;(3)难治性高血压及继发高血压:(4)代谢、心血管方面的疾病;(5)由于自身原因不能进行运动;(6)定期锻炼(每日6000步以上);(7)不良的生活习惯,如酗酒、吸烟;(8)患有心血管疾病的危险分级为高。 b. 排除标准:(1)绝经期之前,不属于以上范畴;(2) SBP、DBP值低于正常范围的临界值(SBP<90mm Hg,DBP<60mm Hg);(3)一般健康、残疾或其他病症;(4)不良的饮食、酗酒、抽烟等;(5)无低危险的心血管危险分级。

Exclusion criteria:

a. Exclusion Criteria: (1) pre-menopausal, not belonging to the above conditions; (2) blood pressure not exceeding the above range; (3) refractory hypertension and secondary hypertension: (4) metabolic and cardiovascular diseases; (5) inability to do exercise due to their own reasons; (6) regular exercise (more than 6,000 steps per day); (7) bad lifestyle habits, such as alcohol abuse, smoking; (8) having cardiovascular disease with a high risk classification. b. Exclusion Criteria: (1) Pre-menopausal, not falling into the above categories; (2) SBP and DBP values below the threshold of the normal range (SBP < 90 mm Hg, DBP < 60 mm Hg); (3) General health, disability or other medical conditions; (4) Poor diet, alcohol abuse, smoking, etc.; (5) No low-risk cardiovascular risk grading.

研究实施时间:

Study execute time:

From 2023-07-25 00:00:00 To 2025-07-25 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-07-25 00:00:00 To 2025-07-25 00:00:00

干预措施:

Interventions:

组别:

联合训练组

样本量:

19

Group:

Combined Training Group (CTG)

Sample size:

干预措施:

健步走+弹力带抗阻

干预措施代码:

Intervention:

Walking + Elastic Band Resistance

Intervention code:

组别:

步行训练组

样本量:

19

Group:

walking training group

Sample size:

干预措施:

健步走

干预措施代码:

Intervention:

walking

Intervention code:

组别:

抗阻训练组

样本量:

19

Group:

resistance training group

Sample size:

干预措施:

弹力带抗阻训练

干预措施代码:

Intervention:

Elastic band resistance training

Intervention code:

组别:

阳性对照组

样本量:

19

Group:

positive control group

Sample size:

干预措施:

维持日常生活方式

干预措施代码:

Intervention:

Maintenance of daily lifestyle

Intervention code:

组别:

阴性对照组

样本量:

19

Group:

negative control group

Sample size:

干预措施:

维持日常生活方式

干预措施代码:

Intervention:

Maintenance of daily lifestyle

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山西 

市(区县):

 

Country:

China

Province:

shanxi

City:

单位(医院):

临汾市中心医院 

单位级别:

三甲 

Institution
hospital:

linfen central hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

蒙特利尔认知评估量表

指标类型:

主要指标

Outcome:

Montreal Cognitive Assessment Scale

Type:

Primary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

简易智能精神状态检查量表

指标类型:

主要指标

Outcome:

Mini Mental State Examination Scale

Type:

Primary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

颈动脉血管超声

指标类型:

次要指标

Outcome:

carotid vascular ultrasound

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

脑血管超声

指标类型:

次要指标

Outcome:

cerebrovascular ultrasound

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

血管内皮功能

指标类型:

次要指标

Outcome:

vascular endothelial function

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

体适能水平

指标类型:

次要指标

Outcome:

fitness level

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

人体形态学指标

指标类型:

次要指标

Outcome:

Human Morphological Indicators

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

指标中文名:

心率变异性

指标类型:

次要指标

Outcome:

heart rate variability

Type:

Secondary indicator

测量时间点:

0周,12周

测量方法:

Measure time point of outcome:

0 weeks, 12 weeks

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 55 years
最大 Max age 65 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

在这项研究中,统计学家将使用SPSS 20.0软件(IBM Corp.,阿蒙克,纽约,美国)在没有参与这项研究的早期阶段生成一个随机数字表。将受试者按1:1:1:1:1的比例随机分54组。

Randomization Procedure (please state who generates the random number sequence and by what method):

In this study, the statistician will use SPSS 20.0 software (IBM Corp., Armonk, New York, NY, USA) to generate a table of randomised numbers at an early stage of the study without participation. Subjects will be randomly divided into 5 groups in a 1:1:1:1:1 ratio.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

NA

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过ResMan提供原始数据查询, http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

IPD will be public accessible via ResMan, http://www.medresman.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据原始资料保存于临汾市中心医院。数据记录采用纸质和电子版病例报告表。电子表的录入由两位秘书独立核对,并最终以数据库形式保存.

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The raw data were kept in Linfen Central Hospital. Data were recorded using both paper and electronic case report forms. Entry into the electronic form was independently checked by two secretaries and eventually kept in a database Storage.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-07-25 16:31:28